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See graph below. Conclusions: Despite improved metabolic parameters with the Atkins’
diet, endothelial function is not improved in Type II diabetics.
1027-198 The Effect of Body Weight Change on Arterial Wall 
Properties
Christos Papamichael, Georgia Vamvakou, Kimon Stamatelopoulos, Konstantinos 
Aznaouridis, Paraskevi Katsichti, Ignatios Oikonomidis, Emmanouil Karatzis, Vasilios 
Sideris, John Lekakis, Myron Mayrikakis, Alexandra Univercity Hospital, Athens, Greece
Background: Excess weight gain in adulthood increases the risk for CAD, hypertension
and diabetes mellitus and is associated with higher intima-medial wall thickness (IMT) of
the carotid artery.
Objective: To examine the effect of weight gain since adolescence on vascular wall prop-
erties.
Methods: Seventy-one healthy individuals (26 men, age 36.5 + 9 years) with a wide
range of body-mass index (BMI, 28.8 + 6.9, 19.3 – 57.9 kgr/m2) without any risk factors
for CAD were examined. Weight change was calculated as the difference between weight
at the baseline examination and self-reported weight at age 18. Each participant was
examined for flow-mediated dilatation (FMD) of the brachial artery, IMT at 3 sites of the
carotid artery and compliance and distensibility in the common carotid artery.
Results: Mean weight gain was 15.9 + 15.1 kgrs (range -15 to 95 kgrs). Weight gain was
significantly correlated with IMT (r=0.339, p<0.005), FMD (r= -0.250, p<0.05) and pulse
pressure (r=0.284, p<0.05). Weight gain was stronger predictor of combined and carotid
bulb IMT when compared to waist to hip ratio (WHR) and BMI. When adjusted for age,
gender, current BMI, WHR and systolic and diastolic blood pressure, weight gain was still
an independent predictor of carotid bulb IMT. Individuals with more than 10 kgr weight
gain had significantly lower FMD (p=0.05), carotid distensibility and compliance (p<0.05)
and higher IMT in the internal carotid artery (p<0.05).
Conclusion: Weight gain in adulthood is an important parameter which significantly
affects vascular wall properties independently of current BMI and body fat distribution.
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1028-165 Obesity Is the Major Determinant of Elevated C-Reactive 
Protein in Subjects With the Metabolic Syndrome
Doron Aronson, Peter Bartha, Arthur Kerner, Walter Markiewicz, Ofir Avizohar, Gerald 
Brook, Yishai Levy, Rambam Medical Center, Haifa, Israel
Introduction: Elevated C-reactive protein (CRP) is strongly associated with characteris-
tics of the metabolic syndrome (MS). However, the relative importance of various compo-
nents of the MS in promoting the inflammatory state is unclear.
Subjects: We conducted a population-based cross sectional study of 1929 apparently
healthy subjects (age 50 ± 10 years; 63% males). Diagnosis of the MS was based on the
ATP III Criteria. The relationship between CRP and the MS was assessed using general
linear models adjusting for age, gender, physical activity, HRT, smoking, BMI, triglycer-
ides, HDL, fasting glucose, and hypertension. 
Results: Subjects with obesity (Ob+) had markedly higher CRP level compared to sub-
jects without obesity (Ob-) regardless of whether they had the MS (Figure A). There was
no significant difference in CRP levels between nonobese subjects without the MS (MS-,
Ob-) and subjects in whom the diagnosis of the metabolic syndrome was based on crite-
ria other than obesity (MS+, Ob-) (P = 0.79). Similarly, CRP levels did not differ among
obese subjects with (MS+, Ob+) and without (MS-, Ob+) the metabolic syndrome (P =
0.99). There was a linear increase in CRP levels with an increase in the number of meta-
bolic disorders (Figure B). However, the relationship substantially diminished after con-
trolling for BMI.
Conclusion: Obesity is the most important contributor to the chronic subclinical inflam-
mation associated with the metabolic syndrome.
* P < 0.005 compared with MS-, Ob-; † P < 0.01 compared with MS+, Ob-;
1028-166 Association of Coronary Heart Disease With Interleukin-
1 Gene Variants in the Atherosclerosis Risk in 
Communities Study
Steven Offenbacher, James D. Beck, James Pankow, Lloyd Chambless, Molly Bray, 
David Couper, Paul M. Martha, Kenneth Huttner, John Rogus, Gordon W. Duff, University 
of North Carolina, Chapel Hill, NC, Interleukin Genetics Inc., Waltham, MA
Background: Current evidence supports the hypothesis that proinflammatory variants of
the interleukin-1 (IL-1) gene cluster are associated with elevated levels of C-reactive pro-
tein and may confer an increased risk of coronary heart disease (CHD).
Methods: To investigate further the relationships between IL-1 and CHD, we analyzed
variations IL-1A(+4845), IL-1B(+3954), IL-1B(-511), and IL-1RN(+2018) in the genes for
IL-1α, IL-1β, and IL-1ra. A subset of the Atherosclerosis Risk in Communities (ARIC)
Study comprising a case sample of 955 with incident CHD (myocardial infarction, fatal
CHD, or cardiac procedure) and a 918-person cohort random sample was used. Propor-
tional hazards regression was done using SAS Proc PHREG with Barlow macro to adjust
for stratified sampling.
Results: Adjusting for age, gender, race, diabetes, smoking, cholesterol, and hyperten-
sion, statistically significant associations in CHD hazard risk ratio (HRR) were demon-
strated for IL-1A(+4845), IL-1B(-511), and IL-1RN(+2018). The strongest genetic
association was found in a subset with total cholesterol <200 mg/dl, a population consid-
ered to be at relatively low risk for CHD. In these 261 cases and 325 non-cases, HRR for
IL-1A(+4845) 2.2 vs.1.1/1.2 was 4.03 (1.58-10.25, p=0.0034). Similar results (HRR=4.95,
p=.0051) were obtained for a sensitivity analysis of 2.2 vs. 1.1, indicating that inclusion of
heterozygotes in the reference group is not pivotal. Significance was achieved in both
racial groups, but the effect in African Americans (HRR=20.3, p=0.00035) is intriguingly
large compared to that in Caucasians (HRR=3.27, p=0.025). The modest number of Afri-
can Americans with a 2.2 genotype (n=7) may play some role in this finding, but bona fide
population differences may also be responsible.
Conclusion: These findings suggest that certain IL-1 gene variants impart an increased
risk for CHD that behaves independently of traditional risk factors such as diabetes and
smoking. Moreover, the importance of IL-1 genes is most apparent in those who are not
already at high risk due to elevated cholesterol.
1028-167 A Synergistic Interaction Between Premature Family 
History of Coronary Heart Disease and Metabolic Risk 
Factors Enhances Risk of Subclinical Atherosclerosis
Khurram Nasir, Joel B. Braunstein, John A. Rumberger, Darshan Dalal, Matthew J. 
Buddoff, Wendy S. Post, Roger S. Blumenthal, Johns Hopkins Medical Institutions, 
Baltimore, MD, Ohio State University, Columbus, OH
Background: Coronary heart disease (CHD) is a complex disease caused by interaction
of a number of genetic and environmental factors. While premature family history (FH) of
CHD is widely recognized as a major risk factor for atherosclerosis, few studies have sug-
gested positive FH to be a marker of increased susceptibility to the deleterious effects of
traditional risk factors (RF). Using an asymptomatic population, we explored the interac-
tion between metabolic RF and premature FH of CHD in predicting presence and severity
of risk coronary artery calcification (CAC).
Methods: We studied 6049 consecutive, physician-referred, asymptomatic, non-diabetic
individuals (55±8 yrs, 67% males) who underwent electron-beam tomography (EBT)
between 1999 and 2002.Metabolic RFs assessed were hypertension, hypertriglyceri-
demia, low HDL and obesity. Participants were classified as low risk (<2 RF) and high-
risk (>2 RF). Synergy index (SI) score and interaction terms were employed in logistic
regression models to assess possible synergism. SI>1 indicates the presence of syner-
gistic interaction. Subclinical atherosclerosis (SCA) was defined as age-gender adjusted
>75th percentile CAC scores.
Results: Seventeen percent (n=1028) of individuals were classified as high risk (>2 RF).
Median, 75th and 90th percentile CAC were significantly greater in high vs. low risk group
(0, 71, 364, vs. 18, 178, 668, respectively, p<0.0001). Increased odds of SCA were
observed with presence of FH in both males (1.7, p<0.0001) and females (1.4, p=0.004).
Significant interaction existed between FH and risk level in prediction of CAC (p=0.01).
After adjusting for potential confounders, the odds associated with high-risk in absence of
FH was 1.3 (95% CI= 1.1-1.3), FH of premature CHD alone (1.5, 1.3-1.8) and combined
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effect (3.2, 2.5-4.2) respectively. The SI score for interaction was 3.6 (95% CI: 3.1-4.2).
Conclusions: Our study demonstrates that a familial propensity to SCA interacts with
presence of increasing metabolic RF, magnifying the risks for those exposed to both.
1028-168 Is Asymmetric Dimethylarginine a Marker for Diabetes, 
Coronary Artery Disease, and Death/Myocardial 
Infarction? Results of the Intermountain Heart 
Collaborative Angiographic Registry Study
Jeffrey L. Anderson, John F. Carlquist, William L. Roberts, Benjamin D. Horne, Tami L. 
Bair, Elisabeth L. Schwarz, Marzia Pasquali, Joseph B. Muhlestein, LDS Hospital, Salt 
Lake City, UT, University of Utah, Salt Lake City, UT
Background: Asymmetric dimethylarginine (ADMA) is an endogenous inhibitor of nitric
oxide synthase that has generated interest as a potential cause or marker of endothelial
dysfunction and its clinical consequences, including diabetes, coronary artery disease
(CAD), and renal failure.
Methods: We tested whether ADMA distinguishes patients (pt) with normal (NFG; <110
mg/dL), or impaired fasting glucose (IFG; 110-125), and diabetes (DM; >126 mg/dL);
angiographic CAD; and death (D) or nonfatal myocardial infarction (MI) in a case-control
cohort of 442 pt selected from the 3 glycemic categories from among 3000 pt entered in
the Intermountain Heart Collaborative Registry. Consenting pt had fasting blood drawn
for FG and ADMA during angiographic assessment and were followed for 2.6 ± 1.4 y.
ADMA was assayed from cryogenically stored samples by high-pressure liquid chroma-
tography with pre-column derivitzation and fluorescence detection. Non-parametric (KW)
testing compared ADMA among groups. Logistic regression was used for predictive mod-
eling.
Results: The study cohort consisted of equal numbers with NFG (146), IFG (148), and
DM (148), matched for age (±5 y) and gender. Overall, age averaged 61 years; 72% were
male; 24%, smokers; 68% had angiographic CAD; 61%, hypertension; 58%, hyperlipi-
demia; 24%, prior MI. During follow-up, 137 events occurred. Distribution of ADMA was
broad and rightward skewed, with median 0.85 µM (range, 0-30). Mean (median) ADMA
levels increased progressively by glycemic category (p<0.001): NFG=2.3 (0.74), IFG=3.0
(0.77), DM= 3.4 (1.27). When adjusted for standard risk factors, CAD severity, and pre-
senting diagnosis, ln ADMA independently predicted DM (odds ratio [OR] 1.29 /ln unit, CI
1.07-1.54, p=0.006) and, less strongly, CAD (OR 1.21, CI 1.0-1.5, p=0.06). Ln ADMA
trended higher in those with D/MI (adjusted OR 1.17, CI 0.98-1.39, p=0.08).
Discussion: Among a high coronary risk case-control cohort, ↑ADMA predicted ↑risk of
IFG, DM, and CAD. Thus, ADMA might contribute to endothelial dysfunction associated
with these conditions. Further research should determine whether ADMA is a causal fac-
tor or passive marker and determine causes of interpatient variability.
1028-169 The Predictive Value of Parental History of Coronary 
Disease
Pamela Ouyang, Lisa R. Yanek, Daniele Fallin, Taryn F. Moy, Lewis C. Becker, Diane M. 
Becker, Johns Hopkins University School of Medicine, Baltimore, MD, Johns Hopkins 
University Bloomberg School of Public Health, Baltimore, MD
Background: Parental history of coronary disease (CHD) is a well-known risk factor for
CHD. However the risk conferred by the gender of an affected parent is controversial and
data are sparse. This prospective study in high risk families was designed to determine
the extent to which a maternal or paternal history of CHD contributed independently to
the risk of incident CHD after adjusting for known risk factors.
Methods: Unaffected siblings (SIBS) of probands were identified from hospitalized index
cases with a documented CHD event < 60 years of age. This prospective analysis
includes 345 women and 339 men with either maternal, paternal or no parent with history
of CHD. Parental family history was elicited by self-report and confirmed by another fam-
ily member. SIBS were followed for incident CHD events. SIB events were documented
by medical records and adjudicated by an external endpoints committee.
Results: The 684 SIBS were 46±7 yrs old at baseline, 50% female, 21% African Ameri-
can, 32% smokers, 7% diabetics, 43% hypertensives, and 67% hypercholesterolemic.
Incident CHD occurred in 84/684 (12.3%) of all SIBS over 8.7±3.2 yrs follow-up. Incident
events occurred in 12.9% of SIBS with no parental history, 10.5%; of sibs with a paternal
history only, and 14.8% of SIBS with a maternal CHD history only. In a Cox proportional
hazard analysis predicting incident CHD in SIBS, the multivariate adjusted relative risk for
maternal CHD was 2.05 (95% CI=1.15-3.65) and for paternal history was 1.0 (95%
CI=0.6-1.66), controlling for age, SIB sex, race, hypertension, current smoking, LDL cho-
lesterol, diabetes, obesity and education.
Conclusion: Among individuals with a documented family history of premature CHD,
having a maternal history of CHD was most strongly associated with the highest risk of a
CHD event. Controlling for known risk factors, maternal history alone conferred a signifi-
cant and independent excess risk of incident CHD whereas paternal alone history was
not significant.
1028-170 Higher Levels of Lipoprotein-Associated Phospholipase 
A2 Are Associated With Higher Incidence of 
Cardiovascular Events at Follow-Up Independent of C-
Reactive Protein
Emmanouil S. Brilakis, Joseph P. McConnell, Jr., Ryan J. Lennon, Ahmad A. Elesber, 
Jeffrey G. Meyers, Peter B. Berger, Mayo Clinic, Rochester, MN
Background: Limited data exist on the association between lipoprotein-associated phos-
pholipase A2 (Lp-PLA2) with cardiovascular risk.
Methods and Results: We measured Lp-PLA2 levels in 504 consecutive patients under-
going clinically indicated coronary angiography. Mean age was 60±11 years and 38%
were women. The mean (± SD) Lp-PLA2 level (ng/mL) was 245 ± 91. Median C-reactive
protein (CRP, mg/L) was 0.29 (interquartile range: 0.12, 0.67). During a median follow-up
of 4.0 years, 58 cardiovascular events occurred in 49 of 466 contacted patients (11%):
cardiac death in 6, acute myocardial infarction (AMI) in 14, coronary revascularization in
28, and stroke in 10. Higher Lp-PLA2 levels were associated with a greater risk of cardio-
vascular events: the hazard ratio (HR) per standard deviation was 1.31 (p=0.010), and
remained significant after adjusting for clinical (age, gender, smoking, hypertension) and
lipid (total and HDL cholesterol, Lp(a), and triglycerides) variables and CRP (Table).
Conclusion: Higher Lp-PLA2 levels were associated with a higher incidence of cardio-
vascular events at follow-up, independently of traditional coronary artery disease risk fac-
tors and CRP.
1028-171 Fasting Blood Glucose: An Underestimated Risk Factor 
for Subclinical Coronary Atherosclerosis
Khurram Nasir, Roger S. Blumenthal, Joel B. Braunstein, Romeu Meneghello, Jose A. 
Maluf, Wendy S. Post, Matthew J. Budoff, Raul D. Santos, Johns Hopkins Medical 
Institutions, Baltimore, MD, Albert Einstein Hospital, Sao Paulo, Brazil
Background: Non-diabetic individuals with high fasting blood glucose (FBG) are at high
risk for experiencing the metabolic syndrome, which includes insulin resistance, hyper-
tension, dyslipidemia, and a procoagulant state. While emerging evidence suggests that
impaired FBG (FBG_110 mg/dl) may accelerate atherosclerosis, we sought to evaluate
the independent impact of FBG in the upper normal range (<110 mg/dl) as a risk factor
for subclinical coronary atherosclerosis assessed by coronary artery calcification (CAC)
in an asymptomatic non-diabetic population.
Methods : We studied 531 consecutive asymptomatic, non-diabetic males (46±7 yrs;
range 29-65 yrs) with FBG<110 mg/dl in the study who presented for electron-beam
computed tomography (EBCT) between 1999 and 2002 in Sao Paulo, Brazil. The popula-
tion was divided into 2 categories; highest quartile of FBG (>85 mg/dl, n=119) and the
lowest three quartiles (n=412).
Results:Individuals in the highest quartile of FBG were more likely to have higher body
mass index (28±4 vs. 26±3, p<0.0001), waist to hip ratio (0.99±0.06 vs. 0.93±0.06,
p=0.01), triglycerides (410±116 vs. 180±92, p=0.05) and systolic blood pressure (131±14
vs.121±13, p<0.0001), where as no significant difference was observed in high density
lipoprotein, low density lipoprotein and total cholesterol levels respectively. Overall
median, 75th percentile and 90th percentile CAC scores were: 3, 24 and 156 among indi-
viduals with highest FBG quartile compared to 0, 6 and 56 among patients with lowest
three quartiles (p<0.05). After adjusting for potential cofounders, the odds ratio for any
calcification (CAC>0) with FBG>85 mg/dl was 2.5 (95% CI=1.1-5.4, p=0.02) and 1.8 (1.1-
3.2, p=0.01) for >75th percentile CAC, respectively
Conclusions: FBG in the upper normal range (>85 mg/dl) appears to be an important
independent predictor of presence and severity of CAC in non-diabetic apparently
healthy young/middle aged men.
1028-172 Increased Urinary 8-Iso-Prostaglandin F2alpha 
Excretion Predict Cardiac Events in Patients With Type 
2 Diabetes
Yusuke Nakagawa, Yoshiyuki Kijima, Akira Nishibe, Nobuyuki Ogasawara, Tamayo 
Ishiko, Megumi Kunishige, Takeshi Hata, Higashiosaka City General Hospital, 
Higashiosaka, Japan
Background: Increased oxidant stress may play a key role in the etiology of diabetic car-
diovascular complications. We hypothesized that increased production of 8-iso-prostag-
landin F2alpha (8-iso-PGF2alpha), a marker for in vivo oxidant stress, predicts future
cardiac events in type 2 diabetic patients.
Methods: We studied 148 patients aged 30-85 (62±10) with type 2 diabetes. Baseline
level of urinary 8-iso-PGF2alpha excretions were measured and the patients were fol-
lowed up for a mean period of 1380 days. Cardiac events were defined as hospitalization
for acute myocardial infarction, unstable angina, revascularization, and worsening heart
failure.
Results: One hundred thirty-nine patients completed the follow-up, while 2 died of non-
cardiac causes. Of the remaining 137 patients, cardiac events were occurred in 16. Uri-
nary 8-iso-PGF2alpha excretion above the median value of 287.5 pg/mg creatinine was
Multivariate association between Lp-PLA2 and CRP with cardiovascular events at 
follow-up.
Endpoint Lp-PLA2
HR (95% confidence 
intervals)
logCRP
HR(95% confidence 
intervals)
Cardiac Death + AMI 1.31 (0.94, 1.81) 1.14 (0.73, 1.79)
Cardiac Death + AMI + Stroke 1.33 (1.02, 1.74) 1.26 (0.86,1.84)
Cardiac Death + AMI + 
Revascularization
1.25 (0.96, 1.64) 1.20 (0.88, 1.64)
Cardiac Death + AMI + 
Revascularization + Stroke
1.29 (1.02, 1.63) 1.26 (0.95, 1.67)
All-Cause Death + AMI 1.30 (1.01, 1.67) 1.35 (0.96, 1.89)
All-Cause Death + AMI + Stroke 1.32 (1.06, 1.65) 1.39 (1.03, 1.89)
All-Cause Death + AMI + 
Revascularization
1.28 (1.02, 1.61) 1.30 (0.99, 1.70)
All-Cause Death + AMI + 
Revascularization + Stroke
1.31 (1.06, 1.60) 1.34 (1.04, 1.72)
